Palatin Techs (PTN) Stock Price, Quote, News & History | Benzinga

Palatin Technologies Inc (PTN) Stock Price, Quote, News & History

PTNNASDAQ

Trade with Public

Trade with Public

$7.50

-0.27-3.47%

Last update: Aug 10, 2:39 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$7.76

Close

-

Volume / Avg.

8.85K / 15.62K

Day Range

$7.50 - $8.20

52 Wk Range

7.21 - 31.00

Market Cap

$13.34M

P/E Ratio

70.64

Dividend Yield

-

Exchange

NASDAQ

RSI

32

Short Interest

17.95%

Days to Cover

10.45

Recent Palatin Technologies Inc News

Why Are Palatin Technologies (PTN) Shares Spiking After-Hours?

Palatin Technologies shares rose in after-hours trading as Janus Henderson Group and its subsidiary reported shared ownership of the company's stock.

Mohd Haider

Abivax Stock Skyrockets On Strong Data From Inflammatory Bowel Disorder Study

Abivax shares jump as obefazimod meets key Phase 3 trial endpoints in ulcerative colitis with strong remission rates and a favorable safety profile.

Vandana Singh

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight

Palatin's study shows co-administering bremelanotide with tirzepatide led to greater weight loss than tirzepatide alone, with further analysis ongoing.

Vandana Singh

Palatin Technologies Touts Positive Results From Mid-Stage Study For Experimental Drug For Ulcerative Colitis, Halts Patients Enrollment Citing Strategic Focus

Palatin's PL8177 showed promising ulcerative colitis trial results, with strong clinical response rates. FDA granted orphan status to its obesity drug PL7737.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.93M

Investing Cash Flow (TTM)

578.70K

Financing Cash Flow (TTM)

21.99M

Free Cash Flow (TTM)

-14.98M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.64M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.95M

PE Ratio (TTM)

70.64

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.24

PB Ratio (TTM)

1.31

Earnings Yield % (TTM)

1.42%

Earnings Yield % (FWD)

-18.66%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.95

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$10.16M

Debt to Equity

0.03

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$7.76

Close

-

Volume / Avg.

8.85K / 15.62K

Day Range

$7.50 - $8.20

52 Wk Range

7.21 - 31.00

Market Cap

$13.34M

P/E Ratio

70.64

Dividend Yield

-

Exchange

NASDAQ

RSI

32

Short Interest

17.95%

Days to Cover

10.45

About

Sector

Health Care

Industry

Biotechnology

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Palatin Techs (PTN) stock?

A

You can purchase shares of Palatin Techs (NASDAQ:PTN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Palatin Techs (PTN) competitors?

A

Other companies in Palatin Techs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Palatin Techs (PTN) stock?

A

Palatin Techs has a consensus price target of $33.50.

Q

What is the current price for Palatin Techs (PTN)?

A

The stock price for Palatin Techs (NASDAQ: PTN) is $7.5 last updated August 10, 2026 at 2:39 PM EDT.

Q

Does Palatin Techs (PTN) pay a dividend?

A

There are no upcoming dividends for Palatin Techs.

Q

When is Palatin Techs (NASDAQ:PTN) reporting earnings?

A

Palatin Techs does not have any upcoming earnings scheduled.

Q

Is Palatin Techs (PTN) going to split?

A

There is no upcoming split for Palatin Techs.

Q

What sector and industry does Palatin Techs (PTN) operate in?

A

Palatin Techs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.